INSIGHT
Policy drives confidence in COVID-19 response
The state of markets across the world suggests the global economy faces only a very minor recession as a result of the COVID-19 outbreak, according to ANZ Research’s indicators. In truth this may be some way away from the actual economic circumstances we face.
While there is a small window for relief in markets as better news filters through, it’s likely at the moment the scenario is priced to perfection and downside risks remain.
The deviation between pricing and reality comes down to two things: the first, continued aggressive policy response from global regulators, particularly in the United States and Europe; the second, positive news on the spread of COVID-19, where hope is being placed on slowing death and infection rates.
In terms of recent encouraging policy response, the US Federal Reserve recently launched a new facility to purchase the debt of downgraded investment-grade companies. That's provided a reasonable amount of confidence in the breadth of coverage from policymakers and showed their willingness to continue to roll out new facilities is high.
In Europe, we saw a facility announced to finance health budgets for countries, with 2 percentage points of gross domestic product added in fiscal policy.
Change
The only thing which has matched the speed of global policy response to the COVID-19 crisis in the pace at which that response continues to develop.To help keep customers keep abreast of that change, ANZ Research has created the ANZ International COVID-19 Policy Response Tracker and the ANZ Australian Government COVID-19 Policy Response Tracker.
These provide a regularly updated overview of fiscal, monetary and macro-prudential measures from key countries around the region and the world, as well as the scope of their impact.
ANZ Research will continue to update the Trackers throughout the crisis. Registration is required for access via ANZ Live.
Bridge
It’s clear the market believes a sufficient bridge is being built between the other side of this viral crisis and today's economic slowdown. ANZ Research is hopeful it is right but believes risk remains.
As such, the conversation needs to turn to the duration of the slowdown and when we can expect to see some normalisation.
In Europe, a couple of countries have indicated they are bringing forward their ‘reopening’. Austria will become a very important place to watch.
On the flipside, we have also seen places like France extend the duration of their lockdowns.
There are a few conclusions to be drawn from this mixed news. The first one, which is obvious, is the countries still struggling with containment are the ones that were slowest to react to the crisis in the first place.
The lesson from that is when economies start to reopen, early action is critical if any second waves occur. Restarting any economy is going to be a sporadic process for as long as we live with COVID-19. Experience suggests authorities should not wait around to see whether or not the spread of the virus going to accelerate.
The second thing is countries with advanced social distancing policies (like Italy, France, the UK and Spain) are not seeing the same pace of slowing as China. What that says is, again, it will be slow going to flatten the curve.
Together with the evidence of early intervention, it is clear there is a real risk the disruption to the global economy will last longer than the market or policymakers hope.
Daniel Been is Head of FX and G3 Research at ANZ
This publication is published by Australia and New Zealand Banking Group Limited ABN 11 005 357 522 (“ANZBGL”) in Australia. This publication is intended as thought-leadership material. It is not published with the intention of providing any direct or indirect recommendations relating to any financial product, asset class or trading strategy. The information in this publication is not intended to influence any person to make a decision in relation to a financial product or class of financial products. It is general in nature and does not take account of the circumstances of any individual or class of individuals. Nothing in this publication constitutes a recommendation, solicitation or offer by ANZBGL or its branches or subsidiaries (collectively “ANZ”) to you to acquire a product or service, or an offer by ANZ to provide you with other products or services. All information contained in this publication is based on information available at the time of publication. While this publication has been prepared in good faith, no representation, warranty, assurance or undertaking is or will be made, and no responsibility or liability is or will be accepted by ANZ in relation to the accuracy or completeness of this publication or the use of information contained in this publication. ANZ does not provide any financial, investment, legal or taxation advice in connection with this publication.